Cardiovascular Manifestations of Pheochromocytoma

被引:38
作者
Gu, Yu Wei [1 ]
Poste, Jennifer [1 ]
Kunal, Mehta [1 ]
Schwarcz, Monica [1 ]
Weiss, Irene [1 ]
机构
[1] New York Med Coll, Westchester Med Ctr, Dept Med, Div Endocrinol, Valhalla, NY 10595 USA
关键词
pheochromocytoma; endocrine hypertension; cardiac manifestations of pheochromocytoma; TAKOTSUBO-LIKE CARDIOMYOPATHY; LAPAROSCOPIC ADRENALECTOMY; MALIGNANT PHEOCHROMOCYTOMA; PERIOPERATIVE MANAGEMENT; FUNCTIONAL PARAGANGLIOMA; ORTHOSTATIC HYPOTENSION; URINARY METANEPHRINES; BIOCHEMICAL-DIAGNOSIS; PLASMA METANEPHRINES; MULTISYSTEM CRISIS;
D O I
10.1097/CRD.0000000000000141
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Pheochromocytomas are rare endocrine tumors that can have a significant impact on a variety of organ systems, including the cardiovascular system. Although the pathophysiology is not completely understood, pheochromocytomas exert their effects through high levels of catecholamines, mainly epinephrine and norepinephrine, which stimulate adrenergic receptors, including those within the cardiovascular system. Although the most common cardiovascular manifestation is hypertension, patients with pheochromocytoma can present with arrhythmia, hypotension, shock, myocardial ischemia, cardiomyopathy, aortic dissection, and peripheral ischemia. The medical management of the cardiovascular effects of pheochromocytoma is via blockade of adrenergic receptors, usually through the use of alpha blockers, with the addition of beta blockers if needed. However, only surgical resection of the pheochromocytoma is potentially curative, and this tumor requires unique management perioperatively. Because of the variability of presentation and the significant morbidity and mortality of patients with an undiagnosed pheochromocytoma, this entity should not be overlooked in the evaluation of patients with a wide variety of cardiovascular disorders.
引用
收藏
页码:215 / 222
页数:8
相关论文
共 105 条
[1]  
Adameova A, 2009, CAN J PHYSIOL PHARM, V87, P493, DOI [10.1139/Y09-042, 10.1139/y09-042]
[2]   Takotsubo-like cardiomyopathy in pheochromocytoma [J].
Agarwal, Vikram ;
Kant, Gunjan ;
Hans, Nidhi ;
Messerli, Franz H. .
INTERNATIONAL JOURNAL OF CARDIOLOGY, 2011, 153 (03) :241-248
[3]   Effects of soybean isoflavones, probiotics, and their interactions on lipid metabolism and endocrine system in an animal model of obesity and diabetes [J].
Ali, AA ;
Velasquez, MT ;
Hansen, CT ;
Mohamed, AI ;
Bhathena, SJ .
JOURNAL OF NUTRITIONAL BIOCHEMISTRY, 2004, 15 (10) :583-590
[4]   Genetic testing in pheochromocytoma or functional paraganglioma [J].
Amar, L ;
Bertherat, J ;
Baudin, E ;
Ajzenberg, C ;
Bressac-de Paillerets, B ;
Chabre, O ;
Chamontin, B ;
Delemer, B ;
Giraud, S ;
Murat, A ;
Niccoli-Sire, P ;
Richard, SP ;
Rohmer, V ;
Sadoul, JL ;
Strompf, L ;
Schlumberger, M ;
Bertagna, X ;
Plouin, PF ;
Jeunemaitre, X ;
Gimenez-Roqueplo, AP .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (34) :8812-8818
[5]   Year of diagnosis, features at presentation, and risk of recurrence in patients with pheochromocytoma or secreting paraganglioma [J].
Amar, L ;
Servais, A ;
Gimenez-Roqueplo, AP ;
Zinzindohoue, F ;
Chatellier, G ;
Plouin, PF .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2005, 90 (04) :2110-2116
[6]   Recurrence or new tumors after complete resection of pheochromocytomas and paragangliomas: a systematic review and meta-analysis [J].
Amar, Laurence ;
Lussey-Lepoutre, Charlotte ;
Lenders, Jacques W. M. ;
Djadi-Prat, Juliette ;
Plouin, Pierre-Francois ;
Steichen, Olivier .
EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2016, 175 (04) :R135-R145
[7]   Diagnosing phaeochromocytoma/paraganglioma in a patient presenting with critical illness: biochemistry versus imaging [J].
Amar, Laurence ;
Eisenhofer, Graeme .
CLINICAL ENDOCRINOLOGY, 2015, 83 (03) :298-302
[8]  
Ariton M, 2000, Endocr Pract, V6, P249
[9]  
AZIZI M, 1994, J HUM HYPERTENS, V8, P69
[10]   Circumstances of discovery of phaeochromocytoma: a retrospective study of 41 consecutive patients [J].
Baguet, JP ;
Hammer, L ;
Mazzuco, TL ;
Chabre, O ;
Mallion, JM ;
Sturm, N ;
Chaffanjon, P .
EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2004, 150 (05) :681-686